Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Thirsty for answers: new study tests if water really quenches thirst

NCT ID NCT07464002

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study investigates if healthy young adults who usually drink little plain water feel thirstier after increasing their water intake for four weeks. Participants will drink about 2 liters of water daily to dilute their urine. The goal is to understand if the body adapts to chronic low water intake and to inform future drinking water guidelines.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Drinking water
What this could lead to
If successful, this study could provide evidence to support specific drinking water recommendations for healthy people.
What could go wrong
This is an early-stage observational study with a small, healthy sample. Results may not apply to the general population or those with health conditions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 120 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

May 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

19 to 29 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

All randomized participants must have complete data from 4 weeks of screening. All inclusion criteria below must be met: * 4 weeks of 3-day mean total water intake of 35 ml/kg body weight * 4 weeks of \<1L/d drinking water * 4 weeks of \<1 hr/d moderate or vigorous physical activity given daily life conditions in Salzburg, Austria * No history of chronic disease * Normal blood pressure, * Normal blood chemistry and complete blood count (CBC) test results * Normal overnight urine concentration, and normal acute urine dilution after 500mL drinking water * Normal weight and height between 160-170 cm for women and 175-185 cm for men) * After overnight food and water restriction urine osmolality above 800 mmol/kg, salivary osmolality above 100 mmol/kg, and a thirst score below 70 mm on a 100 mm visual analog scale. Exclusion Criteria: * Individuals will be excluded from participation if the gender-specific target numbers have already been reached * Perceived stress score of \> 20 at any time during Weeks 1-4 * Schedule that does not allow continuous study participation * Intention to spend more than a day outside the Salzburg area during the study period (to reduce exposure to ground water with different background D2O as potential source of error) * Headache within the last six months * Pregnant, planning a pregnancy, or irregular or unknown menstrual cycle * Active use of tobacco or e-cigarettes * Daily consumption of alcohol * Regular use of medication * Agoraphobia or claustrophobia that would prevent brain fMRI testing * Metal-containing intrauterine device (IUD) that would prevent fMRI testing * Doubtful or unwilling to complete all study procedures (including drinking alcohol; drinking plain tap water, blood tests, 24-hour urine collection, fMRI scans, and stable isotope tests) * Unwilling to be randomly assigned to intervention or control * Incomplete baseline data in Weeks 1-4 (including blood tests, 24-hour urine collection, and MRI scans).

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Aestivation metabolism are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  2. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

More trials for these conditions

Other studies related to the condition(s) this trial covers.